| Literature DB >> 34951310 |
Jun Liu1, Jin-Song Hou1, Yi-Qun Chang2, Li-Jun Peng1, Xiao-Yi Zhang1, Zhi-Ying Miao1, Ping-Hua Sun1, Jing Lin1, Wei-Min Chen1.
Abstract
Development of new bacterial biofilm inhibitors as antibacterial synergists is an effective strategy to solve the resistance of Pseudomonas aeruginosa. In this paper, a series of 3-hydroxy-pyridin-4(1H)-ones were synthesized and evaluated, and the hit compound (20p) was identified with the effects of inhibiting the production of pyocyanin (IC50 = 8.6 μM) and biofilm formation (IC50 = 4.5 μM). Mechanistic studies confirmed that 20p inhibits the formation of bacterial biofilm by inhibiting the expression of pqsA, blocking pqs quorum sensing system quinolone biosynthesis. Moreover, we systematically investigated the bactericidal effects of combining currently approved antibiotics for CF including tobramycin, ciprofloxacin, and colistin E with 20p, which showed obvious antibacterial synergy to overcome antibiotics resistance in multidrug-resistant P. aeruginosa biofilms. The result indicates that compound 20p may be used in the future as a potentially novel antibacterial synergist candidate for the treatment of P. aeruginosa infections.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34951310 DOI: 10.1021/acs.jmedchem.1c01781
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446